Acelrx Pharmaceuticals Inc Revenu
Quel est le Revenu de Acelrx Pharmaceuticals Inc?
Le Revenu de Acelrx Pharmaceuticals Inc est $622.000k
Quelle est la définition de Revenu?
Le revenu est le revenu qu'une entreprise tire de ses activités commerciales normales, généralement de la vente de biens et de services aux clients.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenu des entreprises dans Health Care secteur sur NASDAQ par rapport à Acelrx Pharmaceuticals Inc
Que fait Acelrx Pharmaceuticals Inc?
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Entreprises avec revenu similaire à Acelrx Pharmaceuticals Inc
- New World Resource a Revenu de $605.000k
- Natures Hemp a Revenu de CAD$606.363k
- IQ-AI a Revenu de £608.000k
- Imricor Medical Systems a Revenu de $616.000k
- Oxford BioDynamics Plc a Revenu de £618.000k
- Holy Crp Brands Inc a Revenu de CAD$621.908k
- Acelrx Pharmaceuticals Inc a Revenu de $622.000k
- Medigard a Revenu de AUD$623.740k
- Mondias Natural Products a Revenu de CAD$625.944k
- KWESST Micro Systems a Revenu de CAD$626.195k
- Eurocastle Investment a Revenu de €628.000k
- Spir Communication a Revenu de €633.000k
- ClearVue Technologies a Revenu de AUD$634.000k